Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Hypertension in Pregnancy

• Publication date

  2017-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10641955.2016.1242605PMID 27835040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contingent screening for preterm pre‐eclampsia

  2016cited by this paper
• First‐ and second‐trimester maternal serum markers of pre‐eclampsia in twin pregnancy

  2016cited by this paper
• Optimal first trimester preeclampsia prediction: a comparison of multimarker algorithm, risk profiles and their sequential application

  2016cited by this paper
• Prevention of pre‐eclampsia by low‐molecular‐weight heparin in addition to aspirin: a meta‐analysis

  2016cited by this paper
• Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.

  2016cited by this paper
• Competing risks model in screening for preeclampsia by maternal characteristics and medical history.

  2015influential reference
• Prediction and prevention of early‐onset pre‐eclampsia: impact of aspirin after first‐trimester screening

  2015cited by this paper
• Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling

  2015cited by this paper
• Preeclampsia and Maternal Cardiovascular Disease: Consequence or Predisposition?

  2014cited by this paper
• Cardiovascular Implications in Preeclampsia: An Overview

  2014cited by this paper
• Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy

  2014cited by this paper
• IGFBP-4 and −5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells

  2014cited by this paper
• Uterine artery Doppler, birth weight and timing of onset of pre‐eclampsia: providing insights into the dual etiology of late‐onset pre‐eclampsia

  2014cited by this paper
• Protein Profiling of Preeclampsia Placental Tissues

  2014cited by this paper
• Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.

  2014cited by this paper
• First trimester markers of preeclampsia in twins: maternal mean arterial pressure and uterine artery Doppler pulsatility index

  2014cited by this paper
• Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective study

  2013cited by this paper
• Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia.

  2013cited by this paper
• First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia

  2013cited by this paper
• Sildenafil citrate and uteroplacental perfusion in fetal growth restriction

  2012cited by this paper
• Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies.

  2012cited by this paper
• Economic assessment of screening for pre‐eclampsia

  2012cited by this paper
• Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies.

  2011cited by this paper
• Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks

  2011cited by this paper
• Evaluation and management of severe preeclampsia before 34 weeks' gestation.

  2011cited by this paper
• Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?

  2011cited by this paper
• Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis

  2010cited by this paper
• Proteomics and Down syndrome screening: a validation study

  2010cited by this paper
• Distributions of current and new first‐trimester Down syndrome screening markers in twin pregnancies

  2010cited by this paper
• First‐trimester markers for the prediction of pre‐eclampsia in women with a‐priori high risk

  2010cited by this paper
• American Society of Hypertension. ASH Position Paper: Hypertension in Pregnancy

  2009cited by this paper
• Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks

  2009cited by this paper
• ASH Position Paper: Hypertension in Pregnancy

  2009cited by this paper
• A primate subfamily of galectins expressed at the maternal–fetal interface that promote immune cell death

  2009cited by this paper
• Placental protein 13 as an early marker for pre‐eclampsia: a prospective longitudinal study *

  2008cited by this paper
• Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

  2008cited by this paper
• Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

  2006cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Functional analyses of placental protein 13/galectin-13.

  2004cited by this paper
• Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

  2002cited by this paper
• Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.

  2002cited by this paper
• Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.

  2001cited by this paper
• Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation

  2001cited by this paper
• Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

  2000cited by this paper
• Fetal nutrition and cardiovascular disease in later life.

  1997cited by this paper
• Fetal nutrition and cardiovascular disease in later life.

  1997cited by this paper
• Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US.

  1992cited by this paper

• Minimum test tradeoff applied to uterine artery pulsatility index for antepartum prediction of preeclampsia.

  2025cites this paper
• Construction and validation of a column-line diagram predictive model for the development of preeclampsia in women with twin pregnancies: A retrospective study

  2025cites this paper
• First- and Second-Trimester Uterine Artery Doppler and Hypertensive Disorders in Twin Pregnancies

  2025cites this paper
• Third-Trimester Screening for Preeclampsia in Twins: Comparative Performance of Fetal Medicine Foundation Algorithm, Roche, and Quidel Triages

  2025cites this paper
• Prediction of Preeclampsia in Twins Using First Trimester: cffDNA Fraction, PlGF, and MAP

  2025cites this paper
• Vaccination in twin pregnancies: comparison between immunization before conception and during pregnancy

  2024cites this paper
• Derivation and external validation of prediction model for hypertensive disorders of pregnancy in twin pregnancies: a retrospective cohort study in southeastern China

  2024cites this paper
• Low PAPPA and Its Association with Adverse Pregnancy Outcomes in Twin Pregnancies: A Systematic Review of the Literature and Meta-Analysis

  2024cites this paper
• The potential of repeated mean arterial pressure measurements for predicting early‐ and late‐onset pre‐eclampsia in twin pregnancies: Prediction model study

  2024cites this paper
• Initial establishment and validation of a predictive model for preeclampsia in twin pregnancies based on maternal characteristics and echocardiographic parameters

  2023cites this paper
• A New Model for the Predicting the Risk of Preeclampsia in Twin Pregnancy

  2022cites this paper
• Screening for preeclampsia in twin pregnancies.

  2022cites this paper
• Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review

  2020cites this paper
• The association between urinary placental protein 13 and soluble fms- like tyrosine kinase-1 in preeclamptic women in the third trimester of pregnancy

  2020cites this paper
• Biomarkers of angiogenesis in twin gestations and the risk of preeclampsia - review of the current literature.

  2020cites this paper
• Screening for preeclampsia in low‐risk twin pregnancies at early gestation

  2020cites this paper
• Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration

  2019cites this paper
• FIRST TRIMESTER SCREENING FOR PREECLAMPSIA – A SYSTEMATIC REVIEW

  2019cites this paper
• Maternal serum screening marker levels in twin pregnancies affected by gestational diabetes

  2019cites this paper
• Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy

  2019cites this paper
• Preeclampsia Preeclampsia in twin pregnancy Pré-eclâmpsia na gravidez gemelar

  year unknowncites this paper